271 related articles for article (PubMed ID: 35263081)
1. A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant.
To A; Wong TAS; Lieberman MM; Thompson K; Ball AH; Pessaint L; Greenhouse J; Daham N; Cook A; Narvaez B; Flinchbaugh Z; Van Ry A; Yalley-Ogunro J; Andersen Elyard H; Lai CY; Donini O; Lehrer AT
ACS Infect Dis; 2022 Apr; 8(4):825-840. PubMed ID: 35263081
[TBL] [Abstract][Full Text] [Related]
2. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.
Arunachalam PS; Walls AC; Golden N; Atyeo C; Fischinger S; Li C; Aye P; Navarro MJ; Lai L; Edara VV; Röltgen K; Rogers K; Shirreff L; Ferrell DE; Wrenn S; Pettie D; Kraft JC; Miranda MC; Kepl E; Sydeman C; Brunette N; Murphy M; Fiala B; Carter L; White AG; Trisal M; Hsieh CL; Russell-Lodrigue K; Monjure C; Dufour J; Spencer S; Doyle-Meyers L; Bohm RP; Maness NJ; Roy C; Plante JA; Plante KS; Zhu A; Gorman MJ; Shin S; Shen X; Fontenot J; Gupta S; O'Hagan DT; Van Der Most R; Rappuoli R; Coffman RL; Novack D; McLellan JS; Subramaniam S; Montefiori D; Boyd SD; Flynn JL; Alter G; Villinger F; Kleanthous H; Rappaport J; Suthar MS; King NP; Veesler D; Pulendran B
Nature; 2021 Jun; 594(7862):253-258. PubMed ID: 33873199
[TBL] [Abstract][Full Text] [Related]
3. Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later.
Milligan EC; Olstad K; Williams CA; Mallory M; Cano P; Cross KA; Munt JE; Garrido C; Lindesmith L; Watanabe J; Usachenko JL; Hopkins L; Immareddy R; Shaan Lakshmanappa Y; Elizaldi SR; Roh JW; Sammak RL; Pollard RE; Yee JL; Herbek S; Scobey T; Miehlke D; Fouda G; Ferrari G; Gao H; Shen X; Kozlowski PA; Montefiori D; Hudgens MG; Edwards DK; Carfi A; Corbett KS; Graham BS; Fox CB; Tomai M; Iyer SS; Baric R; Reader R; Dittmer DP; Van Rompay KKA; Permar SR; De Paris K
Sci Transl Med; 2023 Mar; 15(685):eadd6383. PubMed ID: 36454813
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
Lien CE; Kuo TY; Lin YJ; Lian WC; Lin MY; Liu LT; Cheng J; Chou YC; Chen C
Clin Infect Dis; 2022 Jun; 74(11):1899-1905. PubMed ID: 34739037
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a SARS-CoV-2 spike protein ectodomain subunit vaccine with a squalene emulsion adjuvant in rodents and rhesus macaques.
Solomadin M; Tabynov K; Petrovsky N; Tabynov K
Hum Vaccin Immunother; 2023 Aug; 19(2):2258571. PubMed ID: 37880990
[TBL] [Abstract][Full Text] [Related]
6. An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge.
Honda-Okubo Y; Li L; André G; Leong KH; Howerth EW; Bebin-Blackwell AG; Ross TM; Petrovsky N
Vaccine; 2023 Jul; 41(32):4710-4718. PubMed ID: 37355452
[TBL] [Abstract][Full Text] [Related]
7. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
[TBL] [Abstract][Full Text] [Related]
8. Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants.
Honda-Okubo Y; Bowen R; Barker M; Bielefeldt-Ohmann H; Petrovsky N
Vaccine; 2023 Nov; 41(48):7116-7128. PubMed ID: 37863669
[TBL] [Abstract][Full Text] [Related]
9. A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection.
Coria LM; Rodriguez JM; Demaria A; Bruno LA; Medrano MR; Castro CP; Castro EF; Del Priore SA; Hernando Insua AC; Kaufmann IG; Saposnik LM; Stone WB; Prado L; Notaro US; Amweg AN; Diaz PU; Avaro M; Ortega H; Ceballos A; Krum V; Zurvarra FM; Sidabra JE; Drehe I; Baqué JA; Li Causi M; De Nichilo AV; Payes CJ; Southard T; Vega JC; Auguste AJ; Álvarez DE; Flo JM; Pasquevich KA; Cassataro J
Nat Commun; 2024 Feb; 15(1):997. PubMed ID: 38307851
[TBL] [Abstract][Full Text] [Related]
10. Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine.
Richmond PC; Hatchuel L; Pacciarini F; Hu B; Smolenov I; Li P; Liang P; Han HH; Liang J; Clemens R
J Infect Dis; 2021 Nov; 224(10):1699-1706. PubMed ID: 34480575
[TBL] [Abstract][Full Text] [Related]
11. Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates.
Pal R; Ferrari MG; Honda-Okubo Y; Wattay L; Caple J; Navarrete J; Andersen H; Petrovsky N
Vaccine; 2024 Feb; 42(5):1122-1135. PubMed ID: 38262808
[TBL] [Abstract][Full Text] [Related]
12. A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.
Wang S; Wang CY; Kuo HK; Peng WJ; Huang JH; Kuo BS; Lin F; Liu YJ; Liu Z; Wu HT; Ding S; Hou KL; Cheng J; Yang YT; Jiang MH; Wang MS; Chen T; Xia WG; Lin E; Hung CH; Chen HJ; Shih Z; Lin YL; Ryan V; Hu MM; Heppner DG; Malherbe DC; Periasamy S; Kuzmina N; Subramani C; Hellerstein M; Monath TP; Rumyantsev A; Bukreyev A; Guirakhoo F
Emerg Microbes Infect; 2022 Dec; 11(1):2724-2734. PubMed ID: 36287714
[TBL] [Abstract][Full Text] [Related]
13. High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens.
Counoupas C; Pino P; Stella AO; Ashley C; Lukeman H; Bhattacharyya ND; Tada T; Anchisi S; Metayer C; Martinis J; Aggarwal A; Dcosta BM; Britton WJ; Kint J; Wurm MJ; Landau NR; Steain M; Turville SG; Wurm FM; David SA; Triccas JA
Microbiol Spectr; 2022 Feb; 10(1):e0169521. PubMed ID: 35171046
[TBL] [Abstract][Full Text] [Related]
14. A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.
Xu J; Zhang Y; Qu P; Shamseldin MM; Yoo SJ; Misny J; Thongpan I; Kc M; Hall JM; Evans JP; Eltobgy M; Lu M; Ye C; Chamblee M; Liang X; Martinez-Sobrido L; Amer AO; Yount JS; Boyaka PN; Peeples ME; Liu SL; Dubey P; Li J
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2220403120. PubMed ID: 37796985
[TBL] [Abstract][Full Text] [Related]
15. Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants.
Chiu CH; Chang YH; Tao CW; Chang FY; Chiu KC; Chang TW; Yen LC
Microbiol Spectr; 2022 Oct; 10(5):e0060922. PubMed ID: 36005765
[TBL] [Abstract][Full Text] [Related]
16. The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice.
Hu L; Xu Y; Wu L; Feng J; Zhang L; Tang Y; Zhao X; Mai R; Chen L; Mei L; Tan Y; Du Y; Zhen Y; Su W; Peng T
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632595
[TBL] [Abstract][Full Text] [Related]
17. Receptor binding domain proteins of SARS-CoV-2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern.
Khorattanakulchai N; Manopwisedjaroen S; Rattanapisit K; Panapitakkul C; Kemthong T; Suttisan N; Srisutthisamphan K; Malaivijitnond S; Thitithanyanont A; Jongkaewwattana A; Shanmugaraj B; Phoolcharoen W
J Med Virol; 2022 Sep; 94(9):4265-4276. PubMed ID: 35615895
[TBL] [Abstract][Full Text] [Related]
18. Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates.
Pavot V; Berry C; Kishko M; Anosova NG; Li L; Tibbitts T; Huang D; Raillard A; Gautheron S; Gutzeit C; Koutsoukos M; Chicz RM; Lecouturier V
Nat Commun; 2023 Mar; 14(1):1309. PubMed ID: 36894558
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses.
Mandolesi M; Sheward DJ; Hanke L; Ma J; Pushparaj P; Perez Vidakovics L; Kim C; Àdori M; Lenart K; Loré K; Castro Dopico X; Coquet JM; McInerney GM; Karlsson Hedestam GB; Murrell B
Cell Rep Med; 2021 Apr; 2(4):100252. PubMed ID: 33842900
[TBL] [Abstract][Full Text] [Related]
20. Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine.
Arunachalam PS; Feng Y; Ashraf U; Hu M; Walls AC; Edara VV; Zarnitsyna VI; Aye PP; Golden N; Miranda MC; Green KWM; Threeton BM; Maness NJ; Beddingfield BJ; Bohm RP; Scheuermann SE; Goff K; Dufour J; Russell-Lodrigue K; Kepl E; Fiala B; Wrenn S; Ravichandran R; Ellis D; Carter L; Rogers K; Shirreff LM; Ferrell DE; Deb Adhikary NR; Fontenot J; Hammond HL; Frieman M; Grifoni A; Sette A; O'Hagan DT; Van Der Most R; Rappuoli R; Villinger F; Kleanthous H; Rappaport J; Suthar MS; Veesler D; Wang TT; King NP; Pulendran B
Sci Transl Med; 2022 Aug; 14(658):eabq4130. PubMed ID: 35976993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
